Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Midecamycin (Medecamycin A1), an acetoxy-substituted macrolide antibiotic, has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 39.00 | |
50 mg | In stock | $ 56.00 | |
100 mg | In stock | $ 79.00 | |
500 mg | In stock | $ 187.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 39.00 |
Description | Midecamycin (Medecamycin A1), an acetoxy-substituted macrolide antibiotic, has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis. |
In vitro | Midecamycin, a novel 16-membered macrolide antibiotic produced by Streptomyces mycarofaciens, effectively inhibits a substantial portion of streptococci, staphylococci, and strains of Haemophilus and Listeria at concentrations below 3.1 μg/mL [1] [2]. |
Synonyms | Antibiotic SF-837, Turimycin P3, Medecamycin A1, Rubimycin, Platenomycin B1, Espinomycin A |
Molecular Weight | 813.97 |
Formula | C41H67NO15 |
CAS No. | 35457-80-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (73.71 mM)
Ethanol: 50 mg/mL
H2O: Insoluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Midecamycin 35457-80-8 Microbiology/Virology Antibiotic Antibacterial SF837 Antibiotic SF 837 Antibiotic SF-837 Bacterial inhibit Turimycin P3 Medecamycin A1 Inhibitor SF-837 Antibiotic SF837 Rubimycin Platenomycin B1 SF 837 Espinomycin A inhibitor